REPETTO, MATTEO
REPETTO, MATTEO
Universita' degli Studi di MILANO
Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience
2024 E. Crimini, G. Tini, P. Tarantino, L. Ascione, M. Repetto, P. Beria, A. Ranghiero, A. Marra, C. Belli, C. Criscitiello, A. Esposito, E. Guerini Rocco, M.C.P. Barberis, L. Mazzarella, G. Curigliano
The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit
2024 A. Esposito, E. Crimini, C. Criscitiello, C. Belli, R. Scafetta, R. Scalia, G. Castellano, E. Giordano, J. Katrini, L. Ascione, L. Boscolo Bielo, M. Repetto, A. Marra, D. Trapani, G.M. Varano, D. Maiettini, P. Della Vigna, F. Orsi, E. Guerini Rocco, N. Fusco, G. Curigliano
Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience
2023 M. Repetto, E. Crimini, L. Boscolo Bielo, E. Guerini-Rocco, L. Ascione, A. Bonfanti, C. Zanzottera, L. Mazzarella, A. Ranghiero, C. Belli, C. Criscitiello, A. Esposito, M.C.P. Barberis, G. Curigliano
A dynamic approach to supply chain reconfiguration and ripple effect analysis in an epidemic
2023 X. Brusset, D. Ivanov, A. Jebali, D. La Torre, M. Repetto
High-performance prediction models for prostate cancer radiomics
2023 L.J. Isaksson, M. Repetto, P.E. Summers, M. Pepa, M. Zaffaroni, M.G. Vincini, G. Corrao, G.C. Mazzola, M. Rotondi, F. Bellerba, S. Raimondi, Z. Haron, S. Alessi, P. Pricolo, F.A. Mistretta, S. Luzzago, F. Cattani, G. Musi, O. De Cobelli, M. Cremonesi, R. Orecchia, D. La Torre, G. Marvaso, G. Petralia, B.A. Jereczek-Fossa
The Immune-related adverse event (IRAE) Likelihood Score (ILS) identifies “pure” IRAEs strongly associated with outcome in a phase I-II trial population
2022 L. Mazzarella, E. Nicolò, A. Esposito, E. Crimini, G. Tini, J. Uliano, C. Corti, P. Trillo Aliaga, C. Valenza, M. Repetto, G. Antonarelli, I. Minchella, C. Belli, M. Locatelli, C. Criscitiello, G. Curigliano
A set of easy and stringent criteria to identify immune-related adverse events (IrAE Scoring System, ISS) improves correlation with outcome in a phase 1-2 trial population
2022 L. Mazzarella, F. Giugliano, E. Nicolo', E. Crimini, J. Uliano, C. Corti, P. D'Amico, P. Aliaga, C. Valenza, M. Repetto, G. Antonarelli, L. Ascione, G. Vivanet, P. Giachetti, I. Minchella, C. Belli, A. Esposito, M. Locatelli, C. Criscitiello, G. Curigliano
Immune-related adverse events are correlated with significantly improved outcome in a phase I trial population exposed to combination immunotherapy
2021 L. Mazzarella, F. Giugliano, E. Crimini, J. Uliano, C. Corti, P. D'Amico, P. Aliaga, C. Valenza, M. Repetto, E. Nicolo, G. Antonarelli, L. Ascione, G. Vivanet, P. Giachetti, C. Belli, C. Criscitiello, A. Esposito, M. Locatelli, I. Minchella, G. Curigliano
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research
2021 C. Belli, F. Penault-Llorca, M. Ladanyi, N. Normanno, J.-. Scoazec, L. Lacroix, J.S. Reis-Filho, V. Subbiah, J.F. Gainor, V. Endris, M. Repetto, A. Drilon, A. Scarpa, F. Andre, J.-. Douillard, G. Curigliano
Systemic Treatment of Ductal Carcinoma In Situ of the Breast
2021 E. Crimini, C. Corti, M. Repetto, F. Giugliano, G. Antonarelli, P. Tarantino, P. Zagami, S. Morganti, E. Nicolo, J. Uliano, G. Curigliano
Thymic carcinoma with Lynch syndrome or microsatellite instability, a rare entity responsive to immunotherapy
2021 M. Repetto, F. Conforti, S. Pirola, M. Calvello, L. Pala, B. Bonanni, C. Catania, G. Curigliano, T. De Pas
Precision medicine in breast cancer : From clinical trials to clinical practice
2021 E. Crimini, M. Repetto, P. Aftimos, A. Botticelli, P. Marchetti, G. Curigliano
Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions
2021 M. Repetto, E. Crimini, F. Giugliano, S. Morganti, C. Belli, G. Curigliano
Research and clinical landscape of bispecific antibodies for the treatment of solid malignancies
2021 G. Antonarelli, F. Giugliano, C. Corti, M. Repetto, P. Tarantino, G. Curigliano
A robust goal programming model for transfer pricing risk hedging: Preliminary results
2019 M. Repetto, D. La Torre, D. Liuzzi